Blood Collection Biorepository for Liver Disease Research

ConditionsNon-Alcoholic Steatohepatitis(NASH)Hepatitis C Hepatitis B Fibrosis Cirrhosis Fatty Liver Obesity, Childhood Bariatric Surgery Candidate

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age7+

SponsorState University of New York at Buffalo

About this trial

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Eligibility criteria

Qualifiers

This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.

Children and teenagers will be special populations considered in this protocol.

Disqualifiers

Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

State University of New York at Buffalo

Lead sponsor

Source ClinicalTrials.gov